Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen

Research in Veterinary Science

Volumn 89, Issue 1, 2010, Pages 113-119

  Neirinckx, E ^a   Vervaet, C ^a   De Boever, S ^a   Remon, J P ^a   Gommeren, K ^a   Daminet, S ^a   De Backer, P ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Acetaminophen; Bioavailability; First pass metabolism; Pharmacokinetics; Species differences

Indexed keywords

BETA GLUCURONIDASE; DRUG METABOLITE; PARACETAMOL; SULFATASE;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HYDROLYSIS; ENZYME ACTIVITY; FEMALE; FIRST PASS EFFECT; HORSE; NONHUMAN; PLASMA CLEARANCE; PROTEIN HYDROLYSIS; REACTION TIME; SPECIES DIFFERENCE; SWINE; TURKEY (BIRD);

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; ANIMALS, DOMESTIC; BIOLOGICAL AVAILABILITY; CHICKENS; CROSS-OVER STUDIES; DOGS; FEMALE; HORSES; MALE; POULTRY; SPECIES SPECIFICITY; SWINE; TURKEYS;

CANIS FAMILIARIS; EQUIDAE; GALLUS GALLUS; MAMMALIA; SUIDAE;

EID: 77952887372     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.02.002     Document Type: Article

References (56)

1. Ali B.H., Cheng Z., Elhadrami G., Bashir A.K., McKellar Q.A. Comparative pharmacokinetics of paracetamol (acetaminophen) and its sulfate and glucuronide metabolites in desert camels and goats. Journal of Veterinary Pharmacology and Therapeutics 1996, 19:238-244.
2. Ameer B., Divoll M., Abernethy D.R., Greenblatt D.J., Shargel L. Absolute and relative bioavailability of oral acetaminophen preparations. Journal of Pharmaceutical Sciences 1983, 72:955-958.
3. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995, 12:413-420.
4. Anonymous, 1999. Committee for Veterinary Medicinal Products. Paracetamol. Summary Report. EMEA/MRL/511/99-FINAL.
5. Bailie M.B., Federowicz D.A., Dolce K., Kahn C., Mico B.A., Landi M.S. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine. Drug Metabolism and Disposition 1987, 15:729-730.
6. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., Leone S. Paracetamol: new vistas of an old drug. CNS Drug Reviews 2006, 12:250-275.
7. Bock K.W., Bock-Henning B.S., Münzel P.A., Brandenburg J.O., Köhle C.T., Soars M.G., Riley R.J., Burchell B., von Richter O., Eichelbaum M.F. Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by β-naphtoflavone in comparison with humans. Biochemical Pharmacology 2002, 63:1683-1690.
8. Booth N.H. Nonnarcotic analgesics. Veterinary Pharmacology and Therapeutics 1988, 329-362. Iowa State University Press, Ames. sixth ed. N.H. Booth, L.E. McDonald (Eds.).
9. Clements J.A., Critchley J.A.J.H., Prescott L.F. The role of sulfate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. British Journal of Clinical Pharmacology 1984, 18:481-485.
10. Court M.H. Acetaminophen UDP-glucuronosyltransferase in ferrets: species and gender differences, and sequence analysis of ferret UGT1A6. Journal of Veterinary Pharmacology and Therapeutics 2001, 24:415-422.
11. Dimitrova D.J., Lashev L.D., Yanev S.G., Pandova B. Pharmacokinetics of enrofloxacin in turkeys. Research in Veterinary Science 2007, 82:392-397.
12. Dorrestein G.M. Formulation and (bio)availability problems of drug formulations in birds. Journal of Veterinary Pharmacology and Therapeutics 1992, 15:143-150.
13. Dressman J.B. Comparison of canine and human GI physiology. Pharmaceutical Research 1986, 3:123-131.
14. Dyke T.M., Hubbell J.A., Sams R.A., Hinchcliff K.W. Hepatic blood flow in horses during the recuperative period from maximal exercise. American Journal of Veterinary Research 1998, 59:1476-1480.
15. Eandi M., Viano I., Gamalero S.R. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers. Drug Research 1984, 34:903-907.
16. Engelking L.R., Blyden G.T., Lofstedt J., Greenblatt D.J. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses. Journal of Veterinary Pharmacology and Therapeutics 1987, 10:73-82.
17. Farre M., Roset P.N., Abanades S., Menoyo E., Alvarez Y., Rovira M., Baena A. Study of paracetamol 1-g oral solution. Methods and Findings in Experimental and Clinical Pharmacology 2008, 30:37-41.
18. Gasthuys F., De Boever S., Schauvliege S., Reyns T., Levet T., Cornillie P., Casteleyn C., De Backer P., Croubels S. Transsplenic portal catheterization combined with a jugular double-lumen catheter for pharmacokinetic and presystemic metabolization studies in pigs. Journal of Veterinary Pharmacology and Therapeutics 2009, 32:137-145.
19. Gazzard B.G., Ford-Hutchinson A.W., Smith M.J.H., Williams R. The binding of paracetamol to plasma proteins of man and pig. Journal of Pharmacy and Pharmacology 1973, 25:964-967.
20. Graham G.G., Hicks M. Pharmacokinetics and metabolism of paracetamol (acetaminophen). Aspirin and Related Drugs 2004, 181-213. Taylor and Francis, London. K.D. Rainsford (Ed.).
21. Gramatté T., Richter K. Paracetamol absorption from different sites in the human small intestine. British Journal of Clinical Pharmacology 1993, 37:608-611.
22. Greenblatt D.J., Engelking L.R. Enterohepatic circulation of lorazepam and acetaminophen conjugates in ponies. Journal of Pharmacology and Experimental Therapeutics 1988, 244:674-679.
23. Grochowina B., Janus K. Pharmacokinetics of paracetamol in calf plasma and saliva. Medycyna Weterinaria 2006, 62:686-689.
24. Gusson F., Carletti M., Albo A.G., Dacasto M., Nebbia C. Comparison of hydrolytic and conjugative biotransformation pathways in horse, cattle, pig, broiler chick, rabbit and rat liver subcellular fractions. Veterinary Research 2006, 30:271-283.
25. Haritova A.M., Rusenova N.V., Parvanov P.R., Lashev L.D., Fink-Gremmels J. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Antimicrobial Agents and Chemotherapy 2006, 50:3779-3785.
26. Heading R.C., Nimmo J., Prescott L.F., Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. British Journal of Pharmacology 1973, 47:415-421.
27. Janus K., Grochowina B., Antoszek J., Suszycki S., Muszczynski Z. The effect of food or water deprivation on paracetamol pharmacokinetics in calves. Journal of Veterinary Pharmacology and Therapeutics 2003, 26:291-296.
28. Kalantzi L., Reppas C., Dressman J.B., Amidon G.L., Junginger H.E., Midha K.K., Shah V.P., Stavchansky S.A., Barends D.M. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). Journal of Pharmaceutical Sciences 2006, 95:4-14.
29. Kelly K. Gastric emptying of liquids and solids: roles of proximal and distal stomach. American Journal of Physiology 1980, 239:G71-G76.
30. Lennernäs H. Animal data: the contributions of the Ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Advanced Drug Delivery Reviews 2007, 59:1103-1120.
31. Letendre L., Scott M., Dobson G., Hidalgo I., Aungst B. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction. Pharmaceutical Research 2004, 21:1457-1462.
32. Lin J.H. Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition 1995, 23:1008-1021.
33. Martinez M.N. Article III: physicochemical properties of pharmaceuticals. Journal of the American Veterinary Medical Association 1998, 213:1274-1277.
34. Martinez, M.N., 2006. In vivo/in vitro Correlation Studies in Dogs. 2nd Joint AAPS/AAVPT/CRS Workshop on Collaboration in the Research and Development of Veterinary Pharmaceuticals, San Antonio, Texas, October 27-29.
35. Martinez M.N., Amidon G.L. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Journal of Clinical Pharmacology 2002, 42:620-643.
36. Martinez M., Augsburger L., Johnston T., Jones W.W. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations. Advanced Drug Delivery Reviews 2002, 54:805-824.
37. Martinez M., Amidon G., Clarke L., Jones W.W., Mitra A., Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II: physiological considerations. Advanced Drug Delivery Reviews 2002, 54:825-850.
38. Martinez M., Papich M.G., Riviere J.E. Veterinary application of in vitro data and the biopharmaceutics classification system. Pharmacopeial Forum 2004, 30:2-12.
39. Milligan T.P., Morris H.C., Hammond P.M., Price C.P. Studies on paracetamol binding to serum proteins. Annals of Clinical Biochemistry 1994, 31:492-496.
40. Monshouwer M., Witkamp R.F., Pijpers A., Verheijden J.H.M., van Miert A.S.J.P.A.M. Dose-dependent pharmacokinetic interaction between antipyrine and paracetamol in vivo and in vitro when administered as a cocktail in pig. Xenobiotica 1994, 24:347-355.
41. Moffat, A.C., Osselton, M.D., Widdop, B., 2004. Paracetamol. In: Clarke's Analysis of Drugs and Poisons, Third ed. Pharmaceutical Press, London, pp. 1391-1393.
42. Monshouwer M., Witkamp R.F., Nijmeijer S.M., Pijpers A., Verheijden J.H.M., van Miert A.S.J.P.A.M. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, paracetamol, and indocyanine green in the pig. Xenobiotica 1995, 25:491-499.
43. Neirinckx E., Remon J.P., De Backer P., Vervaet C., Croubels S. The biopharmaceutics classification system in veterinary medicine: pH-solubility relationship of analgesic and anti-inflammatory drugs. In: Proceedings of the Tenth International EAVPT Congress. Journal of Veterinary Pharmacology and Therapeutics 2006, 26(Suppl. 1):287-288.
44. Neirinckx, E., Croubels, S., De Boever, S., Remon, J.P., Bosmans, T., Daminet, S., De Backer, P., Vervaet, C., 2010. Species comparison of enantioselective oral bioavailability and pharmacokinetics of ketoprofen. Research in Veterinary Science, submitted for publication.
45. Perucca E., Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. British Journal of Clinical Pharmacology 1979, 7:201-206.
46. Rawlins M.D., Henderson D.B., Hijab A.R. Pharmacokinetics of paracetamol after intravenous and oral administration. European Journal of Clinical Pharmacology 1977, 11:283-286.
47. Reppas C., Eleftheriou G., Macheras P., Symillides M., Dressman J.B. Effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. European Journal of Pharmaceutical Sciences 1998, 6:131-139.
48. Sabnis S. Factors influencing the bioavailability of peroral formulations of drugs for dogs. Veterinary Research Communications 1999, 23:425-447.
49. Souilem O., Gogny M. Particularités de la physiology digestive des volailles. Revue de Médecine Vétérinaire 1994, 145:525-537.
50. St.Omer V.E.V., Mohammad F.K. Effect of antidotal N-acetylcysteine on the pharmacokinetics of acetaminophen in dogs. Journal of Veterinary Pharmacology and Therapeutics 1984, 7:277-281.
51. Sutton S.C. Companion animal physiology and dosage form performance. Advanced Drug Delivery Reviews 2004, 56:1383-1398.
52. Swaan P.W., Marks G.J., Ryan F.M., Smith P.L. Determination of transport rates for arginine and acetaminophen in rabbit intestinal tissues in vitro. Pharmaceutical Research 1994, 11:283-287.
53. Toutain P.L., Bousquet-Mélou A. Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:415-425.
54. Wang L.H., Rudolph A.M., Benet L.Z. Comparative study of acetaminophen disposition in sheep at 3 developmental stages-the fetal, neonatal and adult periods. Developmental Pharmacology and Therapeutics 1990, 14:161-179.
55. Woodbury D.M., Fingl E. Analgesic-antipyretics, anti-inflammatory agents, and drugs employed in the therapy of gout. The Pharmacological Basis of Therapeutics 1975, 325-358. Macmillan, New York. fifth ed. L.S. Goodman, A. Gilman (Eds.).
56. Yamada K., Furuya A., Akimoto M., Maki T., Suwa T., Ogata H. Evaluation of GI transit controlled-beagle dog as a suitable animal model for bioavailability testing of sustained-release acetaminophen dosage form. International Journal of Pharmaceutics 1995, 119:1-10.